OAB stands for overactive bladder, a clinical syndrome defined by a sudden, compelling urge to urinate that is difficult to delay. The formal medical definition, established by the International Urogynecological Association and the International Continence Society, describes OAB as urinary urgency usually accompanied by increased frequency and nighttime urination, with or without leakage, in the absence of a urinary tract infection or other identifiable cause. Roughly 20% of adults worldwide have OAB, with rates climbing to about 28% in people over 60.
The Core Symptoms of OAB
The hallmark of OAB is urgency: a sudden, intense need to urinate that feels impossible to put off. This is what separates OAB from simply needing to go often. That urgency can show up alone, but it typically brings along one or more companion symptoms.
Frequency means urinating more often than normal during waking hours. The conventional threshold is eight or more times in a 24-hour period, though what counts as “too often” varies from person to person. Nocturia, or waking up at night to urinate, is another common feature. Technically, even one nighttime trip counts, but most specialists consider two or more nightly episodes the point where it becomes clinically significant and disruptive to sleep.
Some people with OAB also experience urgency urinary incontinence, which is involuntary leakage triggered by that sudden urge. Clinicians sometimes use the terms “OAB-wet” for people who leak and “OAB-dry” for those who don’t. Both are considered part of the same condition. In the OAB-wet group, the leakage itself tends to be the most bothersome symptom. People with OAB-dry, interestingly, are more likely to report a feeling of incomplete emptying, bladder discomfort, and needing to strain to start urination.
How OAB Differs From Stress Incontinence
OAB is often confused with stress urinary incontinence, but the two have different triggers. In stress incontinence, leakage happens during physical activities that put pressure on the bladder: coughing, sneezing, laughing, or lifting something heavy. There’s no sudden urge beforehand. With OAB, the leak (if it happens at all) follows an overwhelming, out-of-nowhere urge to urinate, regardless of what you’re doing physically. Some people have both conditions simultaneously, which is called mixed incontinence.
What’s Happening in the Bladder
In a normally functioning bladder, the muscle wall (called the detrusor) stays relaxed while the bladder fills and only contracts when you consciously decide to urinate. In OAB, that muscle contracts involuntarily or sends urgency signals before the bladder is actually full. The chemical messenger acetylcholine drives these contractions by binding to specific receptors on the bladder muscle. When those receptors are activated at the wrong time or too strongly, the result is the sudden urgency that defines the condition.
This is also why the most common medications for OAB work by blocking acetylcholine from reaching those receptors, essentially quieting the overactive muscle signals.
Who Gets OAB
OAB affects both men and women but is more common in women, with a prevalence of about 22% compared to 16% in men. Age is the strongest risk factor. Among adults aged 18 to 39, about 11% have OAB. That number rises modestly to around 14% in the 40-to-59 range, then jumps sharply after 60. In men, OAB often coexists with an enlarged prostate, which can contribute to or worsen symptoms. In women, hormonal changes after menopause and pelvic floor weakening play a role.
How OAB Is Diagnosed
OAB is a clinical diagnosis, meaning it’s based entirely on your symptoms rather than a specific lab test or scan. There is no single test that confirms it. A doctor will typically ask about your urinary habits, how often you go, whether you wake at night, and whether you experience leakage. You may be asked to keep a bladder diary for a few days, tracking how much you drink, how often you urinate, and any episodes of urgency or leaking.
Urodynamic testing, which measures pressure and flow in the bladder, is not recommended for initial evaluation. The American Urological Association notes that there are no findings on urodynamic studies that definitively confirm OAB. These tests are generally reserved for cases where the diagnosis is unclear or symptoms don’t respond to treatment. A urinalysis is usually done to rule out a urinary tract infection, since UTI symptoms can closely mimic OAB.
First-Line Treatment: Behavioral Changes
Treatment typically starts with non-drug strategies. Bladder retraining involves gradually increasing the time between bathroom trips, teaching the bladder to hold more urine and reducing the frequency of urgency signals. You start by going on a fixed schedule and slowly extending the interval. Guidelines recommend sticking with bladder retraining for a minimum of six weeks before judging whether it’s working.
Pelvic floor muscle exercises (commonly known as Kegels) strengthen the muscles that help control urination. These are most effective when done under supervision from a physiotherapist or continence specialist, and guidelines recommend committing to at least three months of supervised training. Reducing caffeine and alcohol intake, managing fluid timing, and losing excess weight can also improve symptoms noticeably.
Medications for OAB
If behavioral strategies aren’t enough on their own, medications are the next step. The two main drug classes work in different ways. Anticholinergics block acetylcholine from activating the bladder muscle receptors, reducing involuntary contractions. This increases the volume the bladder can hold comfortably and decreases urgency and frequency. Common side effects include dry mouth, constipation, and in some cases, cognitive effects like memory fog, particularly in older adults.
The other class, beta-3 receptor agonists, works by relaxing the bladder muscle through a completely different pathway. These medications tend to have fewer side effects related to dry mouth and cognition, which makes them a preferred option for many older patients.
Both classes are considered second-line therapy, meaning they’re added to (not substituted for) the behavioral approaches.
When Medications Aren’t Enough
For people whose symptoms don’t improve with behavioral therapy and medication, or who can’t tolerate the side effects, three third-line options are available. Botulinum toxin injections into the bladder wall temporarily paralyze part of the overactive muscle. The effect typically lasts several months before a repeat injection is needed. Sacral neuromodulation uses a small implanted device to send electrical signals to the nerves that control bladder function, similar in concept to a pacemaker. Peripheral tibial nerve stimulation is a less invasive approach where a thin needle near the ankle delivers mild electrical pulses to a nerve connected to the bladder, usually in weekly sessions over several months.
The American Urological Association considers all three options appropriate when second-line treatments fail, and the choice between them depends on the individual’s preferences, symptom severity, and willingness to undergo a procedure.